These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
647 related articles for article (PubMed ID: 15386771)
1. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
2. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making. Brain K; Gravell C; France E; Fiander A; Gray J Gynecol Oncol; 2004 Mar; 92(3):905-13. PubMed ID: 14984959 [TBL] [Abstract][Full Text] [Related]
3. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438 [TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer. Tiller K; Meiser B; Gaff C; Kirk J; Dudding T; Phillips KA; Friedlander M; Tucker K Med Decis Making; 2006; 26(4):360-72. PubMed ID: 16855125 [TBL] [Abstract][Full Text] [Related]
5. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640 [TBL] [Abstract][Full Text] [Related]
6. Women's decisions regarding management of breast cancer risk. MacDonald DJ Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430 [TBL] [Abstract][Full Text] [Related]
7. Psychosocial impact of the lack of information given at referral about familial risk for cancer. Metcalfe A; Werrett J; Burgess L; Clifford C Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207 [TBL] [Abstract][Full Text] [Related]
8. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. Antill Y; Reynolds J; Young MA; Kirk J; Tucker K; Bogtstra T; Wong S; Dudding T; Di Iulio J; Phillips KA Eur J Cancer; 2006 Mar; 42(5):621-8. PubMed ID: 16434187 [TBL] [Abstract][Full Text] [Related]
9. Hereditary breast-ovarian cancer: clinical findings and medical management. Marshall M; Solomon S Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820 [TBL] [Abstract][Full Text] [Related]
10. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ; Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381 [TBL] [Abstract][Full Text] [Related]
11. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study. Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282 [TBL] [Abstract][Full Text] [Related]
12. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses. Brunsvold AN; Wung SF; Merkle CJ J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160 [TBL] [Abstract][Full Text] [Related]
13. Women's awareness of ovarian cancer risks and symptoms. Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232 [TBL] [Abstract][Full Text] [Related]
14. [Recommendations for the management of women with an increased genetic risk of gynaecological cancer]. Verheijen RH; Boonstra H; Menko FH; de Graaff J; Vasen HF; Kenter GG Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2414-8. PubMed ID: 12518519 [TBL] [Abstract][Full Text] [Related]
15. A current perspective on genetic testing for breast and ovarian cancer: the oral contraceptive decision. Friedenson B MedGenMed; 2001 Nov; 3(6):2. PubMed ID: 11965197 [TBL] [Abstract][Full Text] [Related]
16. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome. Roukos DH; Briasoulis E Nat Clin Pract Oncol; 2007 Oct; 4(10):578-90. PubMed ID: 17898808 [TBL] [Abstract][Full Text] [Related]
17. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families. Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing. Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664 [TBL] [Abstract][Full Text] [Related]
19. Development of the breast cancer education and risk assessment program. Snyder LA; Soballe DB; Lahl LL; Nehrebecky ME; Soballe PW; Klein PM Oncol Nurs Forum; 2003; 30(5):803-8. PubMed ID: 12949593 [TBL] [Abstract][Full Text] [Related]
20. Patients' interest in discussing cancer risk and risk management with primary care physicians. Buchanan AH; Skinner CS; Rawl SM; Moser BK; Champion VL; Scott LL; Strigo TS; Bastian L Patient Educ Couns; 2005 Apr; 57(1):77-87. PubMed ID: 15797155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]